Advertisement

FDA expected to quickly approve experimental coronavirus drug Remdesivir: U.S. official

Coronavirus outbreak: Trump, Fauci hopeful about Gilead’s COVID-19 drug Remdesivir
WATCH: Trump, Fauci hopeful about Gilead's COVID-19 drug Remdesivir

The nation’s top infectious diseases expert says he expects the U.S. Food and Drug Administration to quickly approve a new experimental drug that showed promising signs in treating patients with COVID-19.

Anthony Fauci tells NBC’s Today show Thursday that he anticipates the go-ahead for the emergency use of Remdesivir to happen “really quickly.”

Remdesivir: Drug shows promise as COVID-19 treatment
Remdesivir: Drug shows promise as COVID-19 treatment

READ MORE: Archived: Live updates on coronavirus in Canada

Story continues below advertisement

He says he spoke with FDA Commissioner Stephen Hahn on Wednesday, and while Hahn had yet to make a final decision, “I would project that we’re going to be seeing that reasonably soon.” The drug was shown in a major study to shorten recovery time of hospitalized patients.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Fauci said the drug’s manufacturer has committed to scaling production of the drug as quickly as possible as the world hunts for an effective treatment and ultimately a vaccine.

Coronavirus outbreak: Trump, Fauci hopeful about Gilead’s COVID-19 drug Remdesivir
Coronavirus outbreak: Trump, Fauci hopeful about Gilead’s COVID-19 drug Remdesivir

Fauci has been working on a project to fast track the development of a vaccine by mass producing formulas that appear safe and effective before they’re fully vetted. The goal is to get hundreds of millions of doses to the public by January.